Hormone Replacement Therapy

Heart Disease Progression Not Slowed Despite Improvements in Cholesterol

Published in Women's Health Weekly, September 7th, 2000

In the full report of a major study of hormone replacement therapy (HRT) and heart disease, researchers from Wake Forest University Baptist Medical Center write in New England Journal of Medicine that the treatment didn't slow the progression of heart disease in older women, despite improvements in cholesterol levels.

The results of the study, the Estrogen Replacement and Atherosclerosis (ERA) trial, were first announced at the American College of Cardiology's annual meeting in March.

"The evidence suggests that women with heart disease should not use estrogen replacement therapy as a treatment for heart disease," said David Herrington, MD,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2000-09-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry